| Literature DB >> 26725124 |
Sarah Nelson1, David Y Chung2, Guy Rordorf2.
Abstract
Minimal literature exists regarding subocclusive thrombi and their management in acute ischemic stroke, and no randomized trials or guidelines are currently available. We present the case of an 83-year-old man with multiple vascular risk factors and recent cardiac surgery who presented with a severe left middle cerebral artery (MCA) syndrome due to a subocclusive thrombus. Intravenous (IV) tissue plasminogen activator was contraindicated given the patient's recent surgery, and endovascular therapy was deferred given improvement in symptoms. He was placed on IV heparin. His symptoms improved with recanalization of the MCA. Optimal management of subocclusive thrombi, which appear to have better outcomes than occlusive thrombi, has yet to be elucidated. Acute anticoagulation and endovascular therapy may both be reasonable; however, there are minimal data supporting the use of either and further studies are needed to develop the most favorable treatment algorithm. In the meantime, management decisions should be made on a case-by-case basis by multidisciplinary care teams.Entities:
Keywords: Acute ischemic stroke; anticoagulation; computed tomography; endovascular therapy; intraluminal thrombus; subocclusive thrombus
Mesh:
Substances:
Year: 2015 PMID: 26725124 PMCID: PMC7380551 DOI: 10.1016/j.jstrokecerebrovasdis.2015.11.024
Source DB: PubMed Journal: J Stroke Cerebrovasc Dis ISSN: 1052-3057 Impact factor: 2.136